The lipid profiles were favorable, with levels of LDL-C at 3.03 mmol/L, HDL-C at 1.15 mmol/L, TC at 4.94 mmol/L, and TGs at 1.67 mmol/L
These can include: Nausea, vomiting, or bloating Constipation, diarrhoea, or stomach discomfort Indigestion or heartburn Loss of appetite Feeling tired or weak Headache Redness, swelling, itching, or pain at the injection site Rarely, lumps or scarring may occur if injections are not rotated In rare cases, more serious risks can occur and may require immediate medical attention
Diabetes (2016) 65:355260
Finally, extrapolation to the Polish population involves several assumptions and inherent limitations
Psychiatric and psychological adverse effects associated with dulaglutide, semaglutide, and liraglutide: A VigiBase study